Cost-effectiveness of a community-integrated home-based depression intervention in older African Americans

Journal of the American Geriatrics Society

Volumn 62, Issue 12, 2014, Pages 2288-2295

  Pizzi, Laura T ^a   Jutkowitz, Eric ^b   Frick, Kevin D ^c   Suh, Dong Churl ^d   Prioli, Katherine M ^a   Gitlin, Laura N ^e,f,g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Chung Ang University   (South Korea)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

African American; cost; cost effectiveness; depression; health utility

Indexed keywords

CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BEAT THE BLUE; CAREGIVER; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; GROUP THERAPY; HEALTH UTILITIES INDEX 3; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT EDUCATION; PATIENT HEALTH QUESTIONNAIRE SCORE; PATIENT REFERRAL; PROFESSIONAL PRACTICE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; REMISSION; SENSITIVITY ANALYSIS; SOCIAL WORK; SOCIAL WORKER; STRESS MANAGEMENT; COST BENEFIT ANALYSIS; DAILY LIFE ACTIVITY; DEMOGRAPHY; ECONOMICS; HOME CARE; PSYCHOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; COMORBIDITY; COST-BENEFIT ANALYSIS; DEMOGRAPHY; DEPRESSION; FEMALE; HOME CARE SERVICES; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84918813099     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13146     Document Type: Article

References (36)

1. Tai-Seale M, McGuire T, Colenda C, et al. Two-minute mental health care for elderly patients: Inside primary care visits. J Am Geriatr Soc 2007; 55: 1903-1911.
2. Ell K,. Depression care for the elderly: Reducing barriers to evidence-based practice. Home Health Care Serv Q 2006; 24: 115-148.
3. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA 2010; 303: 47-53.
4. Conner KO, Copeland VC, Grote NK, et al. Mental health treatment seeking among older adults with depression: The impact of stigma and race. Am J Geriatr Psychiatry 2010; 18: 531-543.
5. Richardson K, Ananou A, Lafortune L, et al. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging 2011; 28: 547-560.
6. Givens JL, Datto CJ, Ruckdeschel K, et al. Older patients' aversion to antidepressants: A qualitative study. J Gen Intern Med 2006; 21: 146-151.
7. Katon WJ, Schoenbaum M, Fan M, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry 2005; 62: 1313-1320.
8. Kozel FA, George MS, Simpson KN,. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression. CNS Spectr 2004; 9: 476-482.
9. Kendrick T, Chatwin J, Dowrick C, et al. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: The THREAD (THREshold for AntiDepressant response) study. Health Technol Assess 2009; 13: 1-159.
10. Pyne JM, Rost KM, Zhang M, et al. Cost-effectiveness of a primary care depression intervention. J Gen Intern Med 2003; 18: 432-441.
11. Rost K, Pyne JM, Dickinson LM, et al. Cost-effectiveness of enhancing primary care depression management on an ongoing basis. Ann Fam Med 2005; 3: 7-14.
12. Schoenbaum M, Unützer J, Sherbourne C, et al. Cost-effectiveness of practice-initiated quality improvement for depression: Results of a randomized controlled trial. JAMA 2001; 286: 1325-1330.
13. Van Baardewijk M, Vis PMJ, Einarson TR,. Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder. Curr Med Res Opin 2005; 21: 1271-1279.
14. Domino ME, Burns BJ, Silva SG, et al. Cost-effectiveness of treatments for adolescent depression: Results from TADS. Am J Psychiatry 2008; 165: 588-596.
15. Miranda J, Cooper LA,. Disparities in care for depression among primary care patients. J Gen Intern Med 2004; 19: 120-126.
16. Gallo JJ, Bogner HR, Morales KH, et al. Patient ethnicity and the identification and active management of depression in late life. Arch Intern Med 2005; 165: 1962-1968.
17. Neighbors HW, Woodward AT, Bullard KM, et al. Mental health service use among older African Americans: The National Survey of American Life. Am J Geriatr Psychiatry 2008; 16: 948-956.
18. Mills TL, Alea NL, Cheong JA,. Differences in the indicators of depressive symptoms among a community sample of African-American and Caucasian older adults. Community Ment Health J 2004; 40: 309-331.
19. Callahan CM, Hendrie HC,. Editorial: Mental health services research: Moving from academia to the community. Am J Geriatr Psychiatry 2010; 18: 460-463.
20. Alexopoulos GS, Bruce ML,. A model for intervention research in late-life depression. Int J Geriatr Psychiatry 2009; 24: 1325-1334.
21. Gräfe K, Zipfel S, Herzog W, et al. Screening for psychiatric disorders with the Patient Health Questionnaire (PHQ). Results from the German validation study. Diagnostica 2004; 50: 171-181.
22. Kroenke K, Spitzer RL, Williams JB,. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
23. Kroenke K, Spitzer RL,. The PHQ-9: A new depression diagnostic and severity measure. Psychiatr Ann 2002; 32: 509-515.
24. Kales HC, Nease DE, Sirey JA, et al. Racial differences in adherence to antidepressant treatment in later life. Am J Geriatr Psychiatry 2012; 21: 999-1009.
25. Gitlin LN, Harris L, McCoy M, et al. A community-integrated home based depression intervention for older African Americans: Description of the Beat the Blues randomized trial and intervention costs. BMC Geriatr 2012; 12: 1-11.
26. Gitlin LN,. The role of community and home-based interventions in late life depression. In:, Richards CS, O'Hara MW, eds. The Oxford Handbook of Depression and Comorbidity. New York: Oxford University Press, 2014, pp 511-527.
27. Gitlin LN, Harris LF, McCoy MC, et al. A home-based intervention to reduce depressive symptoms and improve quality of life in older African Americans: A randomized trial. Ann Intern Med 2013; 159: 243-252.
28. Gold M,. Panel on cost-effectiveness in health and medicine. Med Care 1996; 34: DS197-DS199.
29. Shaw JW, Johnson JA, Coons SJ,. US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Med Care 2005; 43: 203-220.
30. Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health Qual Life Outcomes 2003; 1: 54.
31. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
32. Shiroiwa T, Sung YK, Fukuda T, et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: What is the threshold of cost effectiveness? Health Econ 2010; 19: 422-437.
33. Currency converter [on-line]. Available at http://www.bloomberg.com/markets/currencies/currency-converter/ Accessed December 18, 2012.
34. Hemels MEH, Kasper S, Walter E, et al. Cost-effectiveness of escitalopram versus citalopram in the treatment of severe depression. Ann Pharmacother 2004; 38: 954-960.
35. Red Book: Pharmacy's Fundamental Reference, 114th Ed. Montvale, NJ: Thomson Reuters (PDR Network), 2010.
36. Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Qual Life Res 2013; 22: 1717-1727.